• 首页
  • 期刊简介
  • 编委会
    第六届编委会
  • 投稿须知
    文章要求
    投稿指南
    发表学术论文“五不准”
  • 本刊稿约
  • 期刊公告
  • 联系我们
引用本文:
【打印本页】   【下载PDF全文】     【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 3011次   下载 0次 本文二维码信息
码上扫一扫!
分享到: 微信 更多
字体:加大+|默认|缩小-
咪唑斯汀对慢性荨麻疹患者IL-4、IFN-γ、IgE水平的影响
胡毅强;李丁纯;欧美莲;
开平市中心医院皮肤科外科
摘要:
目的探讨咪唑斯汀治疗慢性荨麻疹的临床效果及对患者血清白细胞介素-4(IL-4)、γ干扰素(IFN-γ)、免疫球蛋白E(IgE)水平的影响。方法选取我院2015年1月至2016年12月收治的120例慢性荨麻疹患者,采用随机数字表法分为观察组和对照组各60例,分别给予对应药物治疗,对比两组患者的临床症状及实验室指标。结果治疗后,观察组的血清IL-4、IgE水平显著的低于对照组,血清FN-γ水平高于对照组,差异有统计学意义(P<0.05)。治疗后,观察组的风团数目、风团大小、瘙痒程度、风团持续时间、风团发生频率积分均低于对照组,差异有统计学意义(P<0.05)。治疗后,观察组的痊愈率40.00%、显效33.33%、有效20.00%、无效6.67%,对照组痊愈率28.33%、显效26.67%、有效33.33%、无效11.67%,两组比较,差异有统计学意义(P<0.05)。结论咪唑斯汀治疗慢性荨麻疹的临床效果较地氯雷他定更好,对患者血清IL-4、IgE及IFN-γ水平调节效果更好。
关键词:  咪唑斯汀  慢性荨麻疹  白细胞介素-4  γ干扰素  免疫球蛋白E
DOI:
分类号:
基金项目:
Effect of Mizolastine on IL-4,IFN-γ and IgE in Chronic Urticaria Patients
Hu Yiqiang;Li Dingchun;Ou Meilian
Department of Dermatology,Department of Surgery,Kaiping Central Hospital
Abstract:
Objective To investigate the clinical effect of mizolastine in the treatment of chronic urticaria and its effect on serum interleukin-4( IL-4),interferon-γ( IFN-γ) and immunoglobulin E( IgE) in chronic urticaria patients. Methods 120 patients with chronic urticaria admitted in our hospital from January 2015 to December 2016,in accordance with the random number,were divided into observation group and control group( n = 60). The patients were treated with the corresponding medicine. The clinical symptoms and laboratory indicators were evaluated. Results After treatment,the levels of serum IL-4 and Ig E in the observation group were significantly lower than those in the control group( P<0. 05).The serum IFN-γ level in the observation group was higher than that in the control group( P<0. 05).The numbers,sizes,time of duration and frequency of wheal and the itch degree in the observation group were significantly lower than those in the control group( P < 0. 05). The cure rate of the observation group was40. 00%,markedly effective 33. 33%,effective 20. 00%,ineffective 6. 67%,while these parameters in control group was 28. 73%,26. 67%,33. 33% and 11. 67%,respectively. The difference between the two groups was statistically significant( P < 0. 05). Conclusion The efficacy of mizolastine in the treatment of chronic urticaria is better than that of loratadine,and the regulation of serum IL-4,IgE and IFN-γ levels is better.
Key words:  mizolastine  chronicurticaria  interleukin-4  interferon-gamma  immunoglobulinE
您是本站第  88049759  位访问者!蜀ICP备11024768号
版权所有:(C)四川省医疗卫生服务指导中心 2010 CopyRight http://scmj.scyx.org.cn/ all right reserved.
地址:成都市玉林南街2号附3号   电话:028-86136765 邮编:610041
技术支持:北京勤云科技发展有限公司